Briefing: STAT+: As controversial decisions mount, FDA shuns public advisory meetings

Summary

• Summary pending editorial review.

Key Facts

• Key facts pending editorial review.

Sources

• STAT: https://www.statnews.com/2026/03/09/fda-cuts-back-advisory-meetings-controversial-decisions-grow/?utm_campaign=rss